Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best stocks that will always grow. Intuitive Surgical, Inc. (NASDAQ:ISRG) announced on March 2 the completion of its acquisition of the da Vinci ...

Intuitive Surgical has completed the acquisition of da Vinci and Ion distribution businesses in several Southern European countries. The company has received FDA clearance for its da Vinci 5 system ...

Intuitive (Nasdaq: ISRG) announced that it completed its acquisition of the da Vinci and Ion distribution business operated ...

Company begins direct operations in Italy, Spain, Portugal, Malta, San Marino, and associated territoriesSUNNYVALE, Calif., ...

2026 hasn't been a happy New Year so far for Intuitive Surgical (NASDAQ: ISRG) shareholders. The robotic surgical systems stock is in negative territory. And Intuitive's latest quarterly results ...

The surgical robotics giant closed the deal, valued at about 319 million euros upfront, to acquire the businesses in southern ...

Intuitive Surgical's Ion bronchoscopy system during a procedure setup. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...

Intuitive Surgical ISRG has completed the acquisition of the da Vinci and Ion distribution business in Europe in a bid to start direct operations in the region. The company acquired the distribution ...

SUNNYVALE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that ...

Intuitive Surgical’s ISRG third-quarter performance highlights a pivotal shift in its platform mix, with robotic bronchoscopy, formerly a peripheral initiative, rapidly emerging as a core growth ...

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci ...

Intuitive Surgical faces continued challenges in Asia. The company's Ion system replacements are also declining, with lower da Vinci procedure volume growth projected for 2026. However, the value of ...